Those with a BMI of 30 or higher may qualify with at least one additional diagnosed condition such as uncontrolled hypertension, heart failure, or chronic kidney disease
Calcagnile M, Tredici SM, Alifano P (2024) A comprehensive review on probiotics and their use in aquaculture: biological control, efficacy, and safety through the genomics and wet methods
Compare results to your baseline labs
Orally Administered Agents: The development of oral weight-loss medications, such as oral semaglutide (e.g., Novo Nordisk's Rybelsus for diabetes, with potential for weight management), presents a significant competitive threat
Safety Who Should Avoid Retatrutide or Unverified Products